Insmed, Inc. (INSM) Reports Q2 EPS of $0.60; Revs Come in Heavier Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $93.39 -1.76%
EPS Growth %: +77.7%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +77.7%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q2 EPS of $0.60, versus $0.50 reported last year. Revenue for the quarter came in at $3.03 million, versus $2.93 million reported last year.
For earnings history and earnings-related data on Insmed, Inc. (INSM) click here.
For earnings history and earnings-related data on Insmed, Inc. (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- SS&C Technologies shares fall on weak Q4 revenue outlook
- Accenture shares fall on insider sales and analyst downgrade
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
